Sun Pharmaceutical Industries
has completed its acquisition and
begun the integration of its new
opiates business in Australia.
Sun Pharma bought the division
from GlaxoSmithKline earlier this
year (PD 04 Mar), including two
opiates manufacturing facilities in
Port Fairy and Latrobe.
The acquisition allows Sun
Pharma to expand its narcotics raw
material market share and enhance
its opiate alkaloids portfolio, as
well as strengthening its strategic
position in global opiates.
Anil Kumar Jain, ceo of API
Business, Sun Pharma, said the
company will be able to capitalise
on its “global ranking in the
specialty generics market.”The above article was sent to subscribers in Pharmacy Daily's issue from 02 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Sep 15
AUSTRALIA needs more pharmacists than ever, in the face of an ageing population and rising healthcare demands, according to the Pharmaceutical Society of Australia (PSA).
INTERN pharmacists from Monash University are set to join Victoria’s immunisation workforce under a new Secretary Approval by the Victorian Health Department.
VIRTUAL care delivered through telephone or video conference has now embedded itself as a core component of healthcare delivery in NSW, new market reports released today have revealed.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.